Call Us : 1-646-216-8860    |   
Forgot Password? Click Here
image1 image2 image4 image5 image6 image7
FDA PMA Submissions – Contents, Process, Pitfalls
Sheila J. Ramerman, RAC
SJR Associates
Friday, 7th August, 2015
02:00 PM EST | 11:00 AM PST
FDA approvals of Orphan Drugs and Rare Diseases: An evolving competitive landscape
Lori B. Pereira
Founder & Principal
Spectra Health Solutions
Friday, 18th September, 2015
01:00 PM EST | 10:00 AM PST

Executive insights into the FDA "Purple Book" Classification and other FDA initiatives reg...
Dr. Hoss A Dowlat, RA
VP, Global Strategy

Good Distribution Practices
Mary G. Foster, PharmD
Pharma Consulting